ArticleTargeted oncology2015

The HSP90 inhibitor ganetespib potentiates the antitumor activity of EGFR tyrosine kinase inhibition in mutant and wild-type non-small cell lung cancer.

Donald L Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.